Determination of the Rab27-Effector Binding Affinity Using a High-Throughput FRET-Based Assay

Raghdan Z Al-Saad1,2, Ian Kerr3, Alistair N Hume3

  • 1Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, UK. phar.raghdan.zeki@uobabylon.edu.iq.

Insights

Researchers developed a new assay to study Rab27 protein interactions with effector proteins, crucial for cancer metastasis and immune responses. This method helps identify key factors and potential inhibitors of these interactions.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Two Rab27 isoforms, Rab27a and Rab27b, interact with eleven downstream effector proteins, primarily in their GTP-bound state.
  • Rab27-effector protein interactions are implicated in cancer cell invasion, metastasis, and immune/inflammatory responses.

Purpose of the Study:

  • To develop and validate an in vitro fluorescence resonance energy transfer (FRET)-based assay for quantifying Rab27-effector protein interactions.
  • To specifically assess the interaction between human Rab27 (hRab27a/b) and mouse Synaptotagmin-like protein 1 (mSlp1) and mSlp2 effector proteins.

Main Methods:

  • Utilized a FRET-based assay employing recombinant proteins.
  • Green fluorescent protein (GFP)-tagged Rab27 binding domains (m-Slp1, m-Slp2) served as donor fluorophores.
  • mCherry-tagged hRab27a/b proteins acted as acceptor fluorophores.

Main Results:

  • The FRET assay conditions were successfully optimized and validated.
  • The specificity of the developed assay for detecting Rab27-effector interactions was confirmed.
  • The assay demonstrated its capability to measure interactions between hRab27a/b and mSlp1/mSlp2.

Conclusions:

  • A robust and specific in vitro FRET assay for Rab27-effector interactions has been established.
  • This assay can be utilized to identify critical determinants of Rab27-effector binding.
  • The assay serves as a valuable tool for screening and identifying potential inhibitors of Rab27-effector interactions.

Related Concept Videos